Atai Life Sciences N.V. (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATAI | DGX | DVA | CHE | EHC |
| Company | Atai Life Sciences N.V. | Quest Diagnostics Inc | Davita Healthcare Partners Inc | Chemed Inc | Encompass Health Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 2.00 | 136.12 | 136.02 | 573.21 | 85.20 |
| High | 2.07 | 138.37 | 138.47 | 577.91 | 86.52 |
| Low | 1.98 | 136.00 | 135.50 | 571.65 | 85.00 |
| Last | 2.05 | 138.16 | 137.94 | 574.13 | 86.37 |
| Change | +0.04 | +2.02 | +2.09 | +1.42 | +1.08 |
| % Change | +1.99% | +1.48% | +1.54% | +0.25% | +1.27% |
| Volume | 323,240 | 588,253 | 619,091 | 96,402 | 503,823 |
| 20-Day Average Volume | 992,982 | 1,042,708 | 845,565 | 92,340 | 709,136 |
| Previous Close | 2.01 | 136.14 | 135.85 | 572.71 | 85.29 |
| Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.01 | 133.79 | 133.96 | 586.96 | 82.40 |
| 20-Day Raw Stochastic | 33.33% | 74.77% | 63.40% | 25.29% | 97.15% |
| 20-Day Relative Strength | 51.28% | 58.86% | 56.75% | 40.10% | 67.38% |
| Weighted Alpha | +9.35 | +7.32 | +55.42 | +4.07 | +46.26 |
| Today's Opinion | 88% Buy | 72% Buy | 88% Buy | 8% Sell | 100% Buy |
| Previous Opinion | 80% Buy | 56% Buy | 88% Buy | 8% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 80% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.76% since 05/02/24 | +1.33% since 05/02/24 | -3.02% since 05/02/24 | +2.59% since 05/02/24 | +3.54% since 05/02/24 |
| Low | 1.98 on 05/09/24 | 135.26 on 05/03/24 | 131.27 on 05/03/24 | 556.88 on 05/03/24 | 82.83 on 05/03/24 |
| High | 2.29 on 05/03/24 | 138.37 on 05/09/24 | 145.04 on 05/03/24 | 583.63 on 05/07/24 | 86.60 on 05/07/24 |
| 1-Month | |||||
| %Chg | -14.23% since 04/09/24 | +4.08% since 04/09/24 | +2.88% since 04/09/24 | -8.16% since 04/09/24 | +5.39% since 04/09/24 |
| Low | 1.80 on 04/22/24 | 125.42 on 04/18/24 | 125.64 on 04/18/24 | 556.88 on 05/03/24 | 78.53 on 04/18/24 |
| High | 2.55 on 04/12/24 | 142.46 on 04/29/24 | 145.04 on 05/03/24 | 627.12 on 04/10/24 | 86.60 on 05/07/24 |
| 3-Month | |||||
| %Chg | +18.50% since 02/09/24 | +9.01% since 02/09/24 | +25.56% since 02/09/24 | -2.52% since 02/09/24 | +18.43% since 02/09/24 |
| Low | 1.58 on 03/20/24 | 123.30 on 02/21/24 | 108.76 on 02/12/24 | 556.88 on 05/03/24 | 72.38 on 02/12/24 |
| High | 2.85 on 04/04/24 | 142.46 on 04/29/24 | 145.04 on 05/03/24 | 654.62 on 03/15/24 | 86.60 on 05/07/24 |
| 6-Month | |||||
| %Chg | +73.73% since 11/09/23 | +4.95% since 11/09/23 | +63.61% since 11/09/23 | -0.97% since 11/09/23 | +35.84% since 11/09/23 |
| Low | 1.02 on 12/01/23 | 123.04 on 02/01/24 | 82.79 on 11/10/23 | 556.88 on 05/03/24 | 62.58 on 11/10/23 |
| High | 2.85 on 04/04/24 | 143.63 on 01/02/24 | 145.04 on 05/03/24 | 654.62 on 03/15/24 | 86.60 on 05/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 336,500 | 15,124,065 | 11,914,044 | 8,670,251 | 8,587,423 |
| Shares Outstanding, K | 167,413 | 111,092 | 87,700 | 15,139 | 100,685 |
| Annual Sales | 310,000 | 9,252,000,000 | 12,140,150,000 | 2,264,420,000 | 4,801,200,000 |
| Annual Net Income | -40,220,000 | 854,000,000 | 691,540,000 | 272,510,000 | 352,000,000 |
| Last Quarter Sales | 20,000 | 2,366,000,000 | 3,070,560,000 | 589,230,000 | 1,316,000,000 |
| Last Quarter Net Income | -18,290,000 | 194,000,000 | 239,650,000 | 65,020,000 | 112,500,000 |
| 60-Month Beta | 0.92 | 0.88 | 1.04 | 0.46 | 0.92 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 03/28/24 | 2.04 on 04/23/24 | 2.38 on 05/02/24 | 5.20 on 04/24/24 | 1.12 on 04/24/24 |
| Latest Earnings Date | 05/09/24 | 04/23/24 | 05/02/24 | 04/24/24 | 04/24/24 |
| Most Recent Dividend | N/A | 0.710 on 01/16/24 | N/A | 0.400 on 02/23/24 | 0.150 on 03/28/24 |
| Next Ex-Dividends Date | 06/08/17 | 01/16/24 | N/A | 02/23/24 | 06/28/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.72 | 15.00 | 27.23 | 22.13 |